12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Aridis Pharmaceuticals ARDS shares increased by 98.9% to $0.37 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.2 million.
  • VistaGen Therapeutics VTGN stock increased by 38.98% to $0.19. The market value of their outstanding shares is at $40.8 million.
  • Marker Therapeutics MRKR shares increased by 30.83% to $1.74. The market value of their outstanding shares is at $15.3 million.
  • Tenax Therapeutics TENX stock moved upwards by 25.06% to $0.4. The market value of their outstanding shares is at $8.7 million.
  • Freeline Therapeutics FRLN shares moved upwards by 15.99% to $2.9. The market value of their outstanding shares is at $12.5 million. The company's, Q1 earnings came out yesterday.
  • Akebia Therapeutics AKBA shares rose 15.79% to $1.11. The market value of their outstanding shares is at $206.3 million.

Losers

  • Belite Bio BLTE stock fell 44.0% to $13.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $337.7 million.
  • Biodexa Pharmaceuticals BDRX shares declined by 32.82% to $0.09. The company's market cap stands at $1.7 million.
  • Bellicum Pharmaceuticals BLCM shares decreased by 25.09% to $0.57. The company's market cap stands at $5.4 million.
  • NeuBase Therapeutics NBSE stock decreased by 19.93% to $0.14. The company's market cap stands at $4.7 million.
  • Aclarion ACON stock declined by 15.86% to $0.88. The market value of their outstanding shares is at $6.9 million.
  • Phio Pharma PHIO stock decreased by 13.9% to $3.47. The company's market cap stands at $5.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...